Amneal Pharmaceuticals Raises FY26 Revenue View to $3.15B–$3.25B
Story updates
11:04:05 AM UTC
SquawkNews
Amneal Pharmaceuticals Raises FY26 View To Adj EPS $1.04-Adj EPS $1.08 >AMRX
11:15:15 AM UTC
SquawkNews
*--GUIDANCE: (AMRX) Amneal Pharmaceuticals Expects 2026 Revenue Range $3.15B - $3.25B, vs. FactSet Est of $3.16B